KP Tissue Inc. (TSX:KPT)
10.74
-0.16 (-1.47%)
Mar 9, 2026, 1:21 PM EST
KP Tissue Statistics
Total Valuation
KP Tissue has a market cap or net worth of CAD 109.24 million.
| Market Cap | 109.24M |
| Enterprise Value | n/a |
Important Dates
The last earnings date was Wednesday, February 18, 2026.
| Earnings Date | Feb 18, 2026 |
| Ex-Dividend Date | Mar 31, 2026 |
Share Statistics
KP Tissue has 10.02 million shares outstanding. The number of shares has increased by 0.27% in one year.
| Current Share Class | 10.02M |
| Shares Outstanding | 10.02M |
| Shares Change (YoY) | +0.27% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | 0.67% |
| Owned by Institutions (%) | 1.05% |
| Float | 9.96M |
Valuation Ratios
The trailing PE ratio is 12.82 and the forward PE ratio is 14.25.
| PE Ratio | 12.82 |
| Forward PE | 14.25 |
| PS Ratio | n/a |
| PB Ratio | 1.57 |
| P/TBV Ratio | 1.57 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.00
| Current Ratio | 1.00 |
| Quick Ratio | 1.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 12.21%.
| Return on Equity (ROE) | 12.21% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 6.35% |
| Revenue Per Employee | n/a |
| Profits Per Employee | 3,150 |
| Employee Count | 2,700 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +32.22% in the last 52 weeks. The beta is 0.38, so KP Tissue's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | +32.22% |
| 50-Day Moving Average | 10.45 |
| 200-Day Moving Average | 9.71 |
| Relative Strength Index (RSI) | 51.12 |
| Average Volume (20 Days) | 19,653 |
Short Selling Information
The latest short interest is 273,691, so 2.74% of the outstanding shares have been sold short.
| Short Interest | 273,691 |
| Short Previous Month | 279,887 |
| Short % of Shares Out | 2.74% |
| Short % of Float | 2.75% |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | n/a |
| Pretax Income | 8.50M |
| Net Income | 8.50M |
| EBITDA | n/a |
| EBIT | n/a |
| Earnings Per Share (EPS) | 0.85 |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | n/a |
| Net Cash | n/a |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 69.80M |
| Book Value Per Share | 6.97 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.72, which amounts to a dividend yield of 6.61%.
| Dividend Per Share | 0.72 |
| Dividend Yield | 6.61% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 81.88% |
| Buyback Yield | -0.27% |
| Shareholder Yield | 6.34% |
| Earnings Yield | 7.78% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |